Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rousseau

Showing results (81-90 of 524) with videos related to

Pageof 53
Sort By:
Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Cardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Annales D'Endocrinologie|January 1, 1996
[Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)]F Rousseau, J Bonaventure, M Le Merrer, et al.
Acta Cardiologica|January 1, 1973
Effects of a new oral antiarrhythmic drug (Aprindine) on the hemodynamic response to upright exerciseM F Rousseau, L A Brasseur, J M Detry
Lipids in Health and Disease|October 11, 2012
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes femalesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Acta Cardiologica|March 24, 2020
Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelinesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Lipids in Health and Disease|September 14, 2017
The mixed benefit of low lipoprotein(a) in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Revue Medicale De Liege|September 6, 2019
[Post-intensive care syndrome : the issue of life after survival]A F Rousseau, S Piret, D Ledoux, et al.
Diabetes & Metabolism|June 22, 2013
What is the phenotype of patients with gastrointestinal intolerance to metformin?M P Hermans, S A Ahn, M F Rousseau
European Journal of Cardiology|January 1, 1975
Early hemodynamic adaptations to physical training in patients with healed myocardial infarctionJ M Detry, M F Rousseau, L A Brasseur
Pageof 53

Showing results (81-90 of 524) with videos related to

Sort By:
Pageof 53
Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Cardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Annales D'Endocrinologie|January 1, 1996
[Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)]F Rousseau, J Bonaventure, M Le Merrer, et al.
Acta Cardiologica|January 1, 1973
Effects of a new oral antiarrhythmic drug (Aprindine) on the hemodynamic response to upright exerciseM F Rousseau, L A Brasseur, J M Detry
Lipids in Health and Disease|October 11, 2012
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes femalesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Acta Cardiologica|March 24, 2020
Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelinesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Lipids in Health and Disease|September 14, 2017
The mixed benefit of low lipoprotein(a) in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Revue Medicale De Liege|September 6, 2019
[Post-intensive care syndrome : the issue of life after survival]A F Rousseau, S Piret, D Ledoux, et al.
Diabetes & Metabolism|June 22, 2013
What is the phenotype of patients with gastrointestinal intolerance to metformin?M P Hermans, S A Ahn, M F Rousseau
European Journal of Cardiology|January 1, 1975
Early hemodynamic adaptations to physical training in patients with healed myocardial infarctionJ M Detry, M F Rousseau, L A Brasseur
Pageof 53